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Abstract
Background: Mycobacterium lentiflavum (M. lentiflavum), a slow growing nontuberculous mycobacterium (NTM),
has recently been described as an emerging human pathogen regardless of the immune status of the host.
Previous reports have demonstrated that cervical lymphadenitis of children is the most frequent pathology of M.
lentiflavum. However, there are little reports regarding pulmonary diseases by M. lentiflavum specifically in
immunocompetent patients.
Case presentation: A 60-year-old man having prolonged productive cough and dyspnea with fever was initially
diagnosed as pneumonia with parapneumonic effusion. Imaging studies showed that the radiologic abnormality
was acute bronchopneumonic infiltration with abscess formation in the left lower lobe and parapneumonic pleural
effusion. M. lentiflavum was identified in the cultured pleural tissues. On the basis of these findings, he was
diagnosed as pulmonary infection and pleurisy caused by M. lentiflavum, which was treated with a combination of
antibiotics covering NTM. His clinical manifestations were dramatically improved by the treatment targeting NTM,
while those were refractory to empirical antibiotic therapy.
Conclusion: In this report, we introduce the isolation of M. lentiflavum from pleural tissues associated with acute
necrotizing pneumonia combined with parapneumonic effusion in an immunocompetent host, suggesting that the
M. lentiflavum can be a human pathogen invovled in pulmonary infectious diseases and pleurisy with poor
response to empirical antibiotic treatment.
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Background
Mycobacterium lentiflavum (M. lentiflavum), one of
slowly growing nontuberculous mycobacterium (NTM),
was first identified in 1996 as a distinct strain [1]. This
strain is characterized by slow growth of tiny yellow
colonies and has biochemical characteristics identical to
the Mycobacterium avium complex (MAC). In addition,
mycolic acid and fatty acid chromatography patterns are
very similar to those of Mycobacterium simiae [1]. Thus,
the identification of M. lentiflavum is usually confirmed
through genetic analysis. Because like other NTM, M.
lentiflavum is often isolated fortuitously, the clinical
significance must be carefully considered.
Recently several cases of human diseases caused by M.
lentiflavum have been reported, including cervical lymph-
adenitis, fatal disseminated infection, ascites, soft tissue,
liver abscess, and pulmonary infection in immunocompe-
tent and immunosuppressed patients [2–12]. However,
there are few reports on M. lentiflavum as a cause of
pulmonary disease and to date it has rarely been described
in immunocompetent patients.
Herein, we present a case of acute necrotizing pneumonia
combined with parapneumonic effusion caused by M.
lentiflavum in an immunocompetent patient.
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Case presentation
A 60-year-old man was admitted to our hospital with fever,
chills, productive cough, and dyspnea for last two weeks,
which had exacerbated for preceding three days despite
taking oral antibiotics for about 10 days. Since he had been
diagnosed to have bronchial asthma three years ago, he had
taken the combined inhaled medicine of corticosteroid and
a long-acting β2 agonist. However, he had no previous
history of structural lung diseases including pulmonary
tuberculosis and immunocompromised disorders such as
HIV infection. He was an ex-smoker with 20 pack/year
smoking history and his occupation was a farmer. On phys-
ical examination, inspiratory crackles were heard mainly on
the left middle and lower lung fields. Chest radiography
showed pulmonary consolidation with air bronchogram in
the left lower lobe, which also showed fluid shifting sign
(Fig. 1a and b). Chest computed tomography (CT) scan
revealed bronchopneumonic infiltration with abscess for-
mation in the left lower lobe, accompanying left pleural
effusion (Fig. 1c and d). Bacteriologic examinations includ-
ing Gram stain with sputum, pleural fluids, and bronchial
washing fluids revealed no definitive causative organisms.
Pleural tissues were also obtained through needle biopsy,
in which the acute suppurative pleural inflammatory reac-
tion was found and some tissues were cultured to examine
any bacterial or fungal growth. As a result, there was no
Fig. 1 Chest X-ray and chest computed tomography (CT) findings in M. lentiflavum-infected patient. Chest Radiography (a; posteroanterior view,
b; left decubitus view) shows consolidative lesion in the left lower lobe with fluid shifting sign. Chest CT scan revealed that solid consolidative
lesion occupied the left lower lobe with air-bronchogram (c and d). Despite of the antibiotics therapy, the radiologic features were aggravated
showing abscess formation in the left lower lobe, accompanying left pleural effusion and newly developed pneumonic infiltrative lesion on the
right middle lobe (e and f)
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evidence of growth of bacteria or fungi for seven days they
had been cultured.
Firstly, levofloxacin was prescribed as a single intraven-
ous regimen. Up to hospital day 3, however, his clinical
manifestation did not respond to the antibiotic therapy
and even worsened (Fig. 1e and f). We decided to change
the antibiotic regimen to aztreonam and metronidazole as
a combination regimen. On hospital day 7, his symptoms
including fever started to be resolved and then followed
by radiologic improvement on chest radiography. After
his discharge, we got a final bacteriologic report describing
that M. lentiflavum was isolated from pleural specimen bi-
opsied. The antibiotic regimen covering NTM (etambutol,
ciprofloxacin, rifabutin, and clarithromycin) was prescribed
to him in out-patient department, and his remnant lesions
kept being improved (Fig. 2a-c), showing bronchiectasis
and multiple smaller nodules of a tree-in-bud pattern in the
left lingular segment and the left lower lobe (Fig. 2d and e).
Discussion
In 1959, Runyon proposed the first classification system of
mycobacteria in which, based on growth rates, colony
morphology, and pigmentation in the presence and absence
of light, mycobacteria were divided into four groups of hu-
man pathogens; M. tuberculosis complex, M. leprae, slowly
growing NTM, and rapidly growing NTM [13]. The NTM
are usually acquired from environmental sources such as
surface water, tap water, soil, domestic and wild animals,
milk, and food products. Though most species are less
pathogenic or sporadic, they can, in broad terms, induce
four distinct clinical syndromes [14]; 1) Progressive pul-
monary disease, especially in older persons with or with-
out underlying lung disease. 2) Superficial lymphadenitis,
especially cervical lymphadenitis. 3) Disseminated disease
in severely immunocompromised patients. 4) Skin and
soft tissue infection usually as a consequence of direct
inoculation.
Recently, with the availability of 16S ribosomal RNA
sequencing and high-performance liquid chromatography,
and polymerase chain reaction-restriction length poly-
morphism analysis, the number of new species of NTM
including M. lentiflavum has risen dramatically [14, 15]. In
fact, M. lentiflavum, one of slowly growing NTM, was first
identified in a cluster of 22 isolates [1]. Among them, only
one isolate from a vertebral disk in an elderly patient suffer-
ing from spondilodiscitis was clinically significant. Since
then, several cases of isolates from cervical lymphadenitis
of very young children have been reported [2–8]. Other
infected sites including pulmonary infection are less
frequent [1, 4, 6–12].
Typically, pulmonary disease by NTM is characterized as
chronic progressive infectious one which develops both in
healthy persons and in those with underlying pulmonary
disorders or immunosuppressive conditions. The clinical
features may resemble slowly progressive pulmonary tuber-
culosis, which is often the initial diagnosis in patients with
positive results on acid fast bacilli (AFB) staining. Radio-
logic manifestations of pulmonary infection with NTM are
various, to some degree, non-specific including the forma-
tion of solitary or multiple nodules, chronic pneumonitis,
Fig. 2 Serial chest imaging findings in M. lentiflavum-infected patient. At 12 month follow-up, chest imaging studies revealed that the previous
lesions in both lungs were improved remarkably (a-c). In addition, serial chest CT scans showed the distinct bronchiectasis and multiple small
nodular lesions with a tree-in-bud pattern were scattered in the left lingular segment and the left lower lobe (d and e)
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bronchiectasis, cavitary formation, or a combination of
these features.
Altogether, the diagnosis of pulmonary infection with
NTM is extremely difficult due to several factors involved;
these are various clinical and radiologic manifestations, the
frequent presence of significant prior pulmonary disease,
and harmless colonization of NTM in the lower respiratory
tracts. According to American Thoracic Society (ATS)/
Infectious Diseases Society of America (IDSA) guidelines,
the diagnosis should be based on specific, validated criteria
that emphasize a compatible clinical syndrome, character-
istic findings on chest X-ray or CT, and repeated isolation
of NTM from the sputum or growth of NTM from a lung
biopsy [16]. Thus, in cases with these typical radiologic
findings but with negative results of routine sputum
cultures for mycobacteria, physicians have been subse-
quently recommended to perform bronchoscopy and
transbronchial biopsy.
To our knowledge, this report is the first case of acute
necrotizing pneumonia with pleurisy by M. lentiflavum in
an immunocompetent patient without underlying pulmon-
ary structural disorders. In our case, a 60-year-old man
having prolonged productive cough and dyspnea with fever
was initially diagnosed as pneumonia with parapneumonic
effusion. Imaging studies showed that the radiologic abnor-
mality was acute bronchopneumonic infiltration with
abscess formation in the left lower lobe and parapneumonic
pleural effusion. Bacteriologic examinations with sputum,
pleural fluids, and bronchial washing fluids, however,
revealed no definitive causative organisms. Fortunately,
we could confirm that the etiologic organism was M.
lentiflavum found in the cultured pleural tissues, al-
though there is still a possibility of co-infection with
other bacteria such as anaerobes because it is difficult
to culture or isolate anaerobes in several respiratory
samples and the patient was pre-treated with the antibi-
otics that would have negated bacterial cultures or have
activity against co-infected bacteria. On the basis of
these findings, he was diagnosed as pulmonary infection
and pleurisy caused by M. Lentiflavum as at least one of
etiological pathogens, which was treated with a
combination of antibiotics covering NTM.
Conclusions
In light of general information of NTM, this case report
describes several interesting points as follows; the acute
progress of NTM pulmonary diseases, pleural disease by
NTM infection, and occurence of pulmonary infection by
M. lentiflavum in immunocompetent subject. Thus, we
suggest that clinicians should consider the M. lentiflavum
as a human pathogen invovled in lung and pleura regard-
less of immune status. In addition, M. lentiflavum can be
an infectious cause of acute pulmonary disease as well as
chronic pulmonary disease.
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